MiR-425 expression profiling in acute myeloid leukemia might guide the treatment choice between allogeneic transplantation and chemotherapy

BACKGROUND: Acute myeloid leukemia (AML) is a highly heterogeneous disease. MicroRNAs function as important biomarkers in the clinical prognosis of AML. METHODS: This study identified miR-425 as a prognostic factor in AML by screening the TCGA dataset. A total of 162 patients with AML were enrolled...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Transl Med
Päätekijät: Yang, Chen, Shao, Tingting, Zhang, Huihui, Zhang, Ninghan, Shi, Xiaoying, Liu, Xuejiao, Yao, Yao, Xu, Linyan, Zhu, Shengyun, Cao, Jiang, Cheng, Hai, Yan, Zhiling, Li, Zhenyu, Niu, Mingshan, Xu, Kailin
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2018
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6167790/
https://ncbi.nlm.nih.gov/pubmed/30285885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-018-1647-8
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia